Market Overview: The estimated value of the Global Helicobacter Pylori Diagnostics Market in 2019 stood at USD 505.72 million, and it is projected to reach USD 818.29 million by 2027, with a Compound Annual Growth Rate (CAGR) of nearly 6.2% during the forecast period.
Factors fueling market growth include the increasing demand for personalized antibiotic therapy and the improved cost-effectiveness of diagnosing Helicobacter pylori infections. Helicobacter pylori, an aerobic bacteria found in the stomach, plays a role in maintaining stomach ecology but can also lead to infections in the inner stomach lining, contributing to conditions such as stomach cancer, gastritis, duodenal ulcers, small intestine infections, and gastric ulcers. This has spurred a demand for diagnostic methods for Helicobacter pylori infections, with patients typically undergoing a 10 to 14-day antibiotic therapy for ulcers caused by the bacteria.
Get a sample copy of the Helicobacter Pylori Diagnostics Market report: https://www.reportsanddata.com/download-free-sample/3535
While the exact transmission mode of H. pylori is not definitively known, it is presumed to occur through the fecal-oral route. Many H. pylori-infected patients remain asymptomatic, with the majority of cases occurring in childhood.
Helicobacter pylori infections are prevalent in developing nations due to factors like inadequate water supply, dense population, poor sanitation, and low personal hygiene standards. Increasing awareness of H. pylori infections is a key driver for market growth.
The easy accessibility and affordability of antibiotics, coupled with short treatment durations, are expected to boost the adoption of antibiotics and drive demand for pre and post monitoring tests. Additionally, factors such as the rising incidence of H. pylori infections, the need for early symptom detection, and technological advancements in diagnostic techniques contribute to market growth.
In 2019, the immunoassay segment held the largest market share and is expected to maintain its lead throughout the forecast period. Advanced technologies like enzyme immunoassays are employed for antibody detection, including indirect tests such as serology, Urea breath tests, and rapid urease tests. While Point-of-Care (POC) tests are commonly used, molecular diagnostics held the second-largest market share in 2019. Molecular diagnostics, particularly Polymerase Chain Reaction (PCR), offer precise H. pylori identification, especially in areas outside the stomach where cultures often fail.
The hospitals segment dominated the market in 2019 due to ease of disease presentation, doctor accessibility, and the increasing prevalence of diseases like duodenal ulcers, stomach cancer, gastritis, gastric ulcers, and small intestine infections.
The diagnostic laboratories segment is expected to exhibit the fastest CAGR during the forecast period, driven by specialized and efficient infection detection and increasing awareness of infectious diseases. In terms of revenue, the hospitals and diagnostics laboratories segments collectively accounted for over 80% of the market share in 2019.
North America led the market in 2019 due to healthcare infrastructure development and a robust economy. However, Asia Pacific is expected to register the fastest CAGR, attributed to high population growth and an increasing prevalence of H. pylori infections.
The Asia Pacific region faces a major concern with a high prevalence of infectious diseases, driving the demand for helicobacter pylori diagnostics. Poor sanitary conditions and healthcare infrastructure in countries like India are anticipated to further boost test adoption. Moreover, new product launches and the establishment of new manufacturing units by key market players are expected to significantly drive the regional market in the coming years.
Key market players in the helicobacter pylori diagnostics market include Thermo Fisher Scientific, Biohit, Quest Diagnostics, Meridian Bioscience, Bio-Rad Laboratories, Alpha Laboratories, F. Hoffmann-La Roche, Coris BioConcept, Certest Biotec, and Epitope Diagnostics.
Segments covered in the report: This report forecasts volume and revenue growth at the global, regional, and country levels, providing an analysis of industry trends in each sub-segment from 2017 to 2027. For this study, Reports and Data segmented the market based on form, technology, end-user, and region:
By Technology (Revenue, USD Million, 2017 - 2027)
- Immunoassays
- POC
- Molecular Diagnostics
By End-User (Revenue, USD Million, 2017 - 2027)
- Hospitals
- Diagnostics Laboratories
- Clinics
By Region (Revenue, USD Million, 2017 - 2027)
- North America (U.S., Canada)
- Europe (U.K., Germany, France, Italy, Spain, Russia)
- Asia Pacific (Japan, China, India, South Korea, Singapore, Australia)
- Latin America (Brazil, Mexico, Argentina)
- Middle East & Africa (South Africa, Saudi Arabia, UAE)
Explore Trending Reports:
Industrial Coatings Market-https://www.reportsanddata.com/report-detail/industrial-coatings-market
Trivalent Chromium Finishing Market-https://www.reportsanddata.com/report-detail/trivalent-chromium-finishing-market
Cosmetic Chemicals Market-https://www.reportsanddata.com/report-detail/cosmetic-chemicals-market
Coating Additives Market-https://www.reportsanddata.com/report-detail/coating-additives-market
Pigment Dispersion Market-https://www.reportsanddata.com/report-detail/pigment-dispersion-market
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/3535
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
